A new study suggests that the widely used anti-osteoporosis drug, Fosamaxin, may cause fractures, rather than prevent them, writes Ray Moynihan.
Info
Daily Mail
Elsewhere
Policy
Partners
Independent news, blogs and commentary on politics, media, business, the environment and life.
Copyright © 2012 Private Media Pty Ltd, Publishers of Crikey. All Rights Reserved.
Web development by Valegro
Editor: Sophie Black
Publisher: Eric Beecher
Political Correspondent: Bernard Keane
Level 6, 22 William St, Melbourne, 3000
Ph: 1800 985 502
Fax: (03) 8623 9975